Mononuclear cells often infiltrate tumour tissue suggesting that an immune response is generated against the tumours. In colonic carcinomas (Csiba et al., 1984) , breast carcinomas (Rowe & Beverley, 1984) and melanomas (Ralfkiaer et al., 1987) , T lymphocytes have been found to be the predominant mononuclear cell infiltrate. In colonic carcinomas we have shown that the tumour-associated T lymphocytes (TATL) carrying the CD4 phenotype predominanted over the CD8 + cells by a ratio of three to one (submitted for publication).
Since Davis and Newland (1983) . These tissues were reacted with mouse mAb (Table I) and their binding revealed using the avidin-biotin horseradish peroxidase complex (ABC) staining technique (Hsu et al., 1981) employing diaminobenzidine as the substrate. As the mAb used to define the two epitopes of the LCA family, UCHL1 and FMC44, react with (Chen et al., 1984) anti-Tac low affinity IL2R (Dower et al., 1985) formalin-fixed tissues, we used such tissue with these two mAb. In frozen sections the total number of infiltrating leucocytes were identified using a pan-leucocyte marker (FMC 51). In formalin-fixed tissue the amount of the mononuclear cell infiltrate was identified histologically. The proportion of these cells expressing the activation markers was determined using a qualitative scoring system. This system assigned the following values depending on the relative number of cells stained: 0 = no cells stained (similar to negative control); 1 = few and/or sparse; 2 = moderate numbers; 3 = dense; 4 = very dense (i.e. nearly all mononuclear cells stained). Figure 1 summarises the results of this study.
We had previously found that there was a significant reduction in the total number of T lymphocytes in late stage tumours compared to the good prognostic stage A tumours (Natali et al., 1986) . In particular, HLA-DQ + T cells have been reported to be important in effector functions (Navarrete et al., 1986 ) and a DQwl mAb has been shown to block the generation of cytotoxic T cells in a mixed-lymphocyte reaction (MLR) (Corte et al., 1982) .
In those three cases lacking HLA-DQ + cells, the infiltrating cells expressed other 'activation' markers and the total number of infiltrating cells, although reduced in number from that of stage A tumours, was not significantly different from stage B or C tumours where HLA-DQ + cells were readily found.
Expression of IL2R Ralfkiaer et al. (1987) reported that most of the T lymphocyte infiltrate in malignant melanomas expressed the IL2R. However, in our study IL2R + TATL were present in only low density (score ( 1) and only in four of the 18 cases. The lack of reactivity with the anti-IL2R mAb on its own could not rule out the presence of IL2R on the TATL. The anti-Tac mAb reacts only with the low affinity IL2R and the presence of the high affinity IL2R cannot be excluded using this mAb (Smith, 1988) . Furthermore, interleukin 2 released by the TATL and bound to the IL2R on these cells may block the reactivity of this mAb (Leonard et al., 1983 (1988) , who showed that p180 + cells preferentially accumulated in inflammatory lesions. As p180 + and p220 + cells have distinct requirements for lymphokines (Greenbaum et al., 1988) , their recruitment may be influenced by the release of cytokines by other tumour-associated mononuclear cells.
In summary, it appears that most of the TATL in colonic carcinomas may be primed and activated T 
